Ledger.Open graph →

SEC Form D · filed September 29, 2023

Evozyne, Inc

Offering

$100.0M

Sold

$81.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CHICAGO, IL

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Darien S. Parhad · Chicago, ILExec Aris J. Theologis · Chicago, ILExec Patrick J. Morris · Chicago, ILExec · Director Antonio S. Gracias · Chicago, ILDirector Rama J. Ranganathan · Chicago, ILExec · Director Jeffrey S. Aronin · Chicago, ILExec · Director Jude M. Sullivan · Chicago, ILExec Mike S. Gamson · Chicago, ILExec · Director Catherine Covington · SAN FRANCISCO, CAExec Leah Bradford Francis · SAN FRANCISCO, CAExec Rushton G. Mcgarr · Boulder, COExec · Director Justin B. Morales · SAN FRANCISCO, CAExec · Director Meg B. Stallard · SAN FRANCISCO, CAExec · Director Karl Scott · New York, NYDirector Aleina M. Lee · Chicago, ILExec Matthew M. Rizzo · Chicago, ILDirector Arjun S. Rallapalli · Chicago, ILExec Brad Lubrand · Chicago, ILExec Jon R. Mcgurk · Fairlawn, OHExec · Director Jaime U. Kolligian · Fairlawn, OHExec Colin Butterfield · Boston, MAExec · Director Thomas Mclaughlin · San Juan, Puerto RicoExec · Director Amelia K. Siamomua · Vancouver, British Columbia, CanadaDirector Jude M. Sullivan · Chicago, ILExec Aleina M. Lee · Chicago, ILExec Mike S. Gamson · Chicago, ILExec · Director Matthew M. Rizzo · Chicago, ILDirector Arjun S. Rallapalli · Chicago, ILExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗